NATX Plasmids, for: DNA Vaccines, Gene Therapeutics, Viral Vectors andBiophamacueticals

Research and Development
Patents

NTC PRODUCTS AND SERVICES


VECTORS
X
Mammalian Vectors
XAntibiotic-Free Vecotrs
XRig-I Activating Vectors
XpDNAVACCUltra Vector
XLinear Vectors
XRecombineering Vectors
XAutolytic E. coli Cell Lines
XGene Sllencing (transient)
XGene Sllencing (retroviral, stable)
XAnti-Silencing Elements

CELL LINES
XAutolytic E. coli Cell Lines

DNA VACCINES
XXX
DNA Vaccine References
XXX
Pricing
XXXX
PRECISION CLONING
XX
Services and Pricing

RECOMBINANT PROTEINS
X
pVEX™
X
Fluorescent Proteins

PLASMIDS
XSmall Scale Plasmid DNA
XSmall Scale C of A
XLarge Scale Plasmid DNA
XLarge Scale C of A
XPlasmid DNA Order Form
XE. coli Cell paste
XPlasmid Detox Service, NEW!
X
DNA FERMENTATION PROCESS
X
HyperGRO™ Process
X
HyperGRO™ Licensing
X
HyperGRO™ Pricing

PROCESS DEVELOPMENT
X
Process Development Basics
X
Process Licensing

HYPERTAQ™ DNA POLYMERASE


NTC Contacts:

Email: support@natx.com
Phone: (402) 472-6530
Fax: (402) 472-6532

site map | home | contact us



Nature Technology Corporation’s published patent applications relating to genetic immunization,
DNA vaccines and DNA manufacturing
.

1) IMPROVED STRAINS OF E. COLI FOR PLASMID DNA PRODUCTION, Williams, JA, Hodgson, CP (2004) PCT/US2005/28870; WO2006/026125

2) PROCESS FOR PLASMID DNA FERMENTATION, Carnes, AE, Williams, JA (2004) PCT/US2005/29238,
WO2006/023546


3) COMPOSITIONS AND PROCESSES FOR IMPROVED PLASMID DNA PRODUCTION, Williams, JA (2005)
PCT/US2006/03148, WO 2006/081529


4) VECTORS AND METHODS FOR GENETIC IMMUNIZATION, Williams, JA (2005)
PCT/US2006/02174

5) FERMENTATION PROCESS FOR CONTINUOUS PLASMID PRODUCTION, Carnes, AE, (2006)
PCT/US2007/02707.


6) IMPROVED E. COLI PLASMID DNA PRODUCTION, Carnes, AE, Hodgson, CP, Williams, JA (2007)
PCT/US2008/06553


7) PROCESS FOR IMPROVED STRAIN ENGINEERING, Williams, JA, (2007)
PCT/US 008/006548

8) VECTORS AND METHODS FOR GENETIC IMMUNIZATION, Williams, JA (2007)
PCT/US2008/06554

Provisional, Unpublished

9) THERMOSTABLE FUSION PROTEINS AND THERMOSTABLE ADJUVANT, Williams, JA, (2008)
US61/199,651

10)DNA PLASMIDS WITH IMPROVED COPY NUMBER, Williams, JA (2009)
US61/205,561

11) BACTERIAL STRAINS WITH IMPROVED PLASMID STABILITY, Williams, JA (2009)
US61/210,073

Patents

Method of gene transfer using retrotransposons, Hodgson, C.P. (1994): US Patent #5,354,674.

also international filings under Patent Cooperation Treaty, European Patent No. 0506945, issued 7/29/98, Australian Patent No. 699,706.

Mammalian retrotransposons, Hodgson, C.P. (1999): US Patent 5,879,933.


Vectors for Gene Transfer, Hodgson, C.P. (2000): US Patent 6,027,722.


Vectors for Gene Transfer, Hodgson, C.P. (2001): US Patent 6,287,863.


Self-Assembling genes,vectors and uses thereof, Hodgson, C.P., Zink, M.A., and Xu, G.,(2002) US Patent 6,410,220.


Viral packaging signal without gag gene sequences, Hodgson, C.P., Zink, M.A., and Xu, G.,(2003) US Patent 6,573,091.



Contact NTC, Toll free: 1-(888) WIZ-BANG

Plasmids, Recombinant Proteins, DNA Vaccines, Viral Vectors, Therapeutic Genes, Fermentation Technology for Gene Therapy and Biotechnology
NTC's free resource "Site" for the biotechnology industry,
including Databases and Sequences Analysis Tool
s



WWW http://www.natx.com